Michael Tarzi

Dr. Michael Tarzi is an Associate Professor (Honorary Consultant) in Clinical Immunology at Brighton and Sussex Medical School (BSMS), part of the University of Sussex. He serves as Immunology theme lead for module 204 and Phase 2 Lead, demonstrating significant academic leadership within the medical school.

His expertise spans several key areas in immunology:

• Allergy and allergic disease mechanisms
• Diagnostic immunology
• Primary immunodeficiency disorders
• C1 inhibitor deficiency and hereditary angioedema
• Pollen-food syndrome

Dr. Tarzi's research has significantly contributed to national guidelines and consensus documents, particularly in the management of C1 inhibitor deficiency. His work bridges clinical practice and academic research, with numerous publications in high-impact journals including Clinical and Experimental Immunology, Allergy, and the New England Journal of Medicine.

His notable scientific contributions include:

• Co-authoring the 2014 United Kingdom consensus document on C1 inhibitor deficiency
• Contributing to a landmark 2017 NEJM study on prevention of hereditary angioedema attacks
• Leading research on T cell responses in allergic disease
• Conducting national audits on hereditary angioedema service provision

As an educator, Dr. Tarzi has shaped medical curriculum development at BSMS since 2008, with particular focus on immunology education for medical students. His dual role as academic and Honorary Consultant ensures his teaching remains clinically relevant and up-to-date with current practice.

Dr. Tarzi has secured research funding, including a project on "Viscero-sensory processes and neural responses to inflammation: mechanisms of pain and fatigue in fibromyalgia" funded by ARTHRITIS RESEARCH UK from 2016-2020, demonstrating his ability to obtain competitive research grants.